APA (7th ed.) Citation

WS, A., JS, V., WH, N., J, P., NP, P., M, K., . . . M, K. (1974). Halofenate, serum lipids, and exercise performance in coronary heart disease. Clinical pharmacology and therapeutics, 15(1), 67. https://doi.org/10.1002/cpt197415167

Chicago Style (17th ed.) Citation

WS, Aronow, Vangrow JS, Nelson WH, Pagano J, Papageorge's NP, Khursheed M, Harding PR, and Khemka M. "Halofenate, Serum Lipids, and Exercise Performance in Coronary Heart Disease." Clinical Pharmacology and Therapeutics 15, no. 1 (1974): 67. https://doi.org/10.1002/cpt197415167.

MLA (9th ed.) Citation

WS, Aronow, et al. "Halofenate, Serum Lipids, and Exercise Performance in Coronary Heart Disease." Clinical Pharmacology and Therapeutics, vol. 15, no. 1, 1974, p. 67, https://doi.org/10.1002/cpt197415167.